Cargando…
Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy
PURPOSE: To investigate the value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in the differential diagnosis of lymphoma in patients with fever of unknown origin (FUO) accompanied by lymphadenopathy and to develop a simple scoring system to di...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374793/ https://www.ncbi.nlm.nih.gov/pubmed/36884116 http://dx.doi.org/10.1007/s00432-023-04665-7 |
_version_ | 1785078854142918656 |
---|---|
author | Chen, Jia Xu, Dong Sun, Wen-Jin Wang, Wen-Xia Xie, Na-Na Ruan, Qiu-Rong Song, Jian-Xin |
author_facet | Chen, Jia Xu, Dong Sun, Wen-Jin Wang, Wen-Xia Xie, Na-Na Ruan, Qiu-Rong Song, Jian-Xin |
author_sort | Chen, Jia |
collection | PubMed |
description | PURPOSE: To investigate the value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in the differential diagnosis of lymphoma in patients with fever of unknown origin (FUO) accompanied by lymphadenopathy and to develop a simple scoring system to distinguish lymphoma from other etiologies. METHODS: A prospective study was conducted on patients with classic FUO accompanied by lymphadenopathy. After standard diagnostic procedures, including PET/CT scan and lymph-node biopsy, 163 patients were enrolled and divided into lymphoma and benign groups according to the etiology. The diagnostic utility of PET/CT imaging was evaluated, and beneficial parameters that could improve diagnostic effectiveness were identified. RESULTS: The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of PET/CT in diagnosing lymphoma in patients with FUO accompanied by lymphadenopathy were 81.0, 47.6, 59.3, and 72.7%, respectively. The lymphoma prediction model combining high SUVmax of the “hottest” lesion, high SUVmax of the retroperitoneal lymph nodes, old age, low platelet count, and low ESR had an area under the curve of 0.93 (0.89–0.97), a sensitivity of 84.8%, a specificity of 92.9%, a PPV of 91.8%, and an NPV of 86.7%. There was a lower probability of lymphoma for patients with a score < 4 points. CONCLUSIONS: PET/CT scans show moderate sensitivity and low specificity in diagnosing lymphoma in patients with FUO accompanied by lymphadenopathy. The scoring system based on PET/CT and clinical parameters performs well in differentiating lymphoma and benign causes and can be used as a reliable noninvasive tool. REGISTRATION NUMBER: This study on FUO was registered on http://www.clinicaltrials.gov on January 14, 2014, with registration number NCT02035670. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04665-7. |
format | Online Article Text |
id | pubmed-10374793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-103747932023-07-29 Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy Chen, Jia Xu, Dong Sun, Wen-Jin Wang, Wen-Xia Xie, Na-Na Ruan, Qiu-Rong Song, Jian-Xin J Cancer Res Clin Oncol Research PURPOSE: To investigate the value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in the differential diagnosis of lymphoma in patients with fever of unknown origin (FUO) accompanied by lymphadenopathy and to develop a simple scoring system to distinguish lymphoma from other etiologies. METHODS: A prospective study was conducted on patients with classic FUO accompanied by lymphadenopathy. After standard diagnostic procedures, including PET/CT scan and lymph-node biopsy, 163 patients were enrolled and divided into lymphoma and benign groups according to the etiology. The diagnostic utility of PET/CT imaging was evaluated, and beneficial parameters that could improve diagnostic effectiveness were identified. RESULTS: The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of PET/CT in diagnosing lymphoma in patients with FUO accompanied by lymphadenopathy were 81.0, 47.6, 59.3, and 72.7%, respectively. The lymphoma prediction model combining high SUVmax of the “hottest” lesion, high SUVmax of the retroperitoneal lymph nodes, old age, low platelet count, and low ESR had an area under the curve of 0.93 (0.89–0.97), a sensitivity of 84.8%, a specificity of 92.9%, a PPV of 91.8%, and an NPV of 86.7%. There was a lower probability of lymphoma for patients with a score < 4 points. CONCLUSIONS: PET/CT scans show moderate sensitivity and low specificity in diagnosing lymphoma in patients with FUO accompanied by lymphadenopathy. The scoring system based on PET/CT and clinical parameters performs well in differentiating lymphoma and benign causes and can be used as a reliable noninvasive tool. REGISTRATION NUMBER: This study on FUO was registered on http://www.clinicaltrials.gov on January 14, 2014, with registration number NCT02035670. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04665-7. Springer Berlin Heidelberg 2023-03-08 2023 /pmc/articles/PMC10374793/ /pubmed/36884116 http://dx.doi.org/10.1007/s00432-023-04665-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Chen, Jia Xu, Dong Sun, Wen-Jin Wang, Wen-Xia Xie, Na-Na Ruan, Qiu-Rong Song, Jian-Xin Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy |
title | Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy |
title_full | Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy |
title_fullStr | Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy |
title_full_unstemmed | Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy |
title_short | Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy |
title_sort | differential diagnosis of lymphoma with (18)f-fdg pet/ct in patients with fever of unknown origin accompanied by lymphadenopathy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374793/ https://www.ncbi.nlm.nih.gov/pubmed/36884116 http://dx.doi.org/10.1007/s00432-023-04665-7 |
work_keys_str_mv | AT chenjia differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy AT xudong differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy AT sunwenjin differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy AT wangwenxia differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy AT xienana differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy AT ruanqiurong differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy AT songjianxin differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy |